{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T11:39:06Z","timestamp":1791545946352,"version":"4.3.4"},"reference-count":59,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2022,7,15]],"date-time":"2022-07-15T00:00:00Z","timestamp":1657843200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100014382","name":"Ipsen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014382","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Journal of Medical Economics"],"published-print":{"date-parts":[[2022,12,31]]},"DOI":"10.1080\/13696998.2022.2092354","type":"journal-article","created":{"date-parts":[[2022,6,22]],"date-time":"2022-06-22T08:25:25Z","timestamp":1655886325000},"page":"919-929","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":9,"title":["The cost-effectiveness of abobotulinumtoxinA (Dysport) and onabotulinumtoxinA (Botox) for managing spasticity of the upper and lower limbs, and cervical dystonia"],"prefix":"10.1080","volume":"25","author":[{"given":"Natalya","family":"Danchenko","sequence":"first","affiliation":[{"name":"Ipsen, Boulogne-Billancourt, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karissa M.","family":"Johnston","sequence":"additional","affiliation":[{"name":"Broadstreet Health Economics and Outcomes Research, Vancouver, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Whalen","sequence":"additional","affiliation":[{"name":"Ipsen Slough, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2022,7,15]]},"reference":[{"key":"e_1_3_4_2_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.e4845"},{"key":"e_1_3_4_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1331.2010.03128.x"},{"key":"e_1_3_4_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1331.2010.03132.x"},{"key":"e_1_3_4_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1331.2010.03129.x"},{"key":"e_1_3_4_6_1","unstructured":"Mayo Clinic. Cervical dystonia. 2021. [cited 2021 Jun 22]. https:\/\/www.mayoclinic.org\/diseases-conditions\/cervical-dystonia\/symptoms-causes\/syc-20354123?lang=en."},{"key":"e_1_3_4_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.rehab.2009.09.005"},{"key":"e_1_3_4_8_1","doi-asserted-by":"publisher","DOI":"10.1002\/mds.22157"},{"key":"e_1_3_4_9_1","unstructured":"Dysport powder for solution for injection. 2020. [cited 2020 Oct 12]. https:\/\/www.medicines.org.uk\/emc\/product\/7261\/smpc."},{"key":"e_1_3_4_10_1","unstructured":"Botox powder for solution for injection. 2020. [cited 2020 Oct 12]. https:\/\/www.medicines.org.uk\/emc\/product\/859\/smpc."},{"issue":"2","key":"e_1_3_4_11_1","first-page":"115","article-title":"Comparison of different preparations of botulinum toxin a in the treatment of cervical dystonia","volume":"17","author":"Brockmann K","year":"2012","unstructured":"Brockmann K, Schweitzer K, Beck G, et\u00a0al. Comparison of different preparations of botulinum toxin a in the treatment of cervical dystonia. Neurol Asia. 2012;17(2):115\u2013119.","journal-title":"Neurol Asia"},{"key":"e_1_3_4_12_1","doi-asserted-by":"crossref","unstructured":"Jacinto J Ashford S Fheodoroff K et\u00a0al. Real-life data on the time to retreatment with botulinum toxin a in upper limb spasticity management. World Congress for NeuroRehabilitation 2020; October 7\u201311 Virtual Congress.","DOI":"10.1016\/j.toxicon.2020.11.409"},{"key":"e_1_3_4_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2020.04.903"},{"key":"e_1_3_4_14_1","doi-asserted-by":"publisher","DOI":"10.1177\/0883073819830579"},{"key":"e_1_3_4_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.apmr.2019.01.016"},{"key":"e_1_3_4_16_1","doi-asserted-by":"publisher","DOI":"10.1177\/0269215513491274"},{"key":"e_1_3_4_17_1","doi-asserted-by":"publisher","DOI":"10.1177\/0269215517745348"},{"key":"e_1_3_4_18_1","doi-asserted-by":"publisher","DOI":"10.1080\/13696998.2021.1957582"},{"key":"e_1_3_4_19_1","doi-asserted-by":"crossref","unstructured":"Turner-Stokes L Ashforda S Jacintod J et\u00a0al. Economic outcomes in real-world use of botulinum toxin-A products for adult patients with upper limb spasticity: a UK perspective. Paper presented at: TOXINS 2021; January 16\u201317 2021.","DOI":"10.1016\/j.toxicon.2020.11.497"},{"key":"e_1_3_4_20_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0036-1571302"},{"key":"e_1_3_4_21_1","unstructured":"Turner-Stokes L Ashford S Fheodoroff K et\u00a0al. The GAS-eous tool: goal attainment scaling - evaluation of outcome for upper-limb spasticity. 2013. https:\/\/www.kcl.ac.uk\/cicelysaunders\/resources\/tools\/gas-eous"},{"key":"e_1_3_4_22_1","doi-asserted-by":"publisher","DOI":"10.2340\/16501977-2801"},{"key":"e_1_3_4_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2020.04.927"},{"key":"e_1_3_4_24_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00702-012-0887-7"},{"key":"e_1_3_4_25_1","unstructured":"National Institute for Health and Care Excellence. Guide to the methods of technology appraisal. 2013. https:\/\/www.nice.org.uk\/process\/pmg9\/chapter\/the-reference-case."},{"key":"e_1_3_4_26_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2012-000881"},{"key":"e_1_3_4_27_1","doi-asserted-by":"crossref","unstructured":"Jacinto J Ashford S Fheodoroff K et\u00a0al. Factors associated with favorable response in real-world use of botulinum toxin a products for adult patients with upper limb spasticity. TOXINS 2022; July 27\u201330 2022 New Orleans LA.","DOI":"10.1016\/j.toxicon.2021.11.065"},{"key":"e_1_3_4_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2020.04.906"},{"key":"e_1_3_4_29_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2007-0016"},{"key":"e_1_3_4_30_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2015-2830"},{"key":"e_1_3_4_31_1","doi-asserted-by":"publisher","DOI":"10.1017\/S0317167100014049"},{"key":"e_1_3_4_32_1","unstructured":"NHS England. National Tariff 2019\/20: Non-mandatory prices. 2019. https:\/\/www.england.nhs.uk\/publication\/national-tariff-payment-system-documents-annexes-and-supporting-documents\/"},{"key":"e_1_3_4_33_1","unstructured":"Gracies J-M Francisco G Jech R et\u00a0al. The effect of guided self-rehabilitation contracts combined with simultaneous injections of abobotulinumtoxinA into upper and lower limbs on voluntary movements in adults with spastic hemiparesis. IPMDS International Congress; Sept 24 2019 Nice France."},{"key":"e_1_3_4_34_1","unstructured":"British National Formulary [Internet]. British Medical Association and Royal Pharmaceutical Society of Great Britain. 2020. [cited 2020 Jan 10]. https:\/\/bnf.nice.org.uk\/."},{"key":"e_1_3_4_35_1","unstructured":"NHS Improvement. 2017\/18 Reference costs: national schedule of reference costs. 2020."},{"key":"e_1_3_4_36_1","volume-title":"Unit costs of health and social care 2019","author":"Curtis L","year":"2019","unstructured":"Curtis L, Burns A. Unit costs of health and social care 2019. Canterbury (UK): University of Kent; 2019."},{"key":"e_1_3_4_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pmrj.2011.10.001"},{"key":"e_1_3_4_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.apmr.2008.01.007"},{"key":"e_1_3_4_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2021.04.797"},{"key":"e_1_3_4_40_1","volume-title":"Acute migraine medication and medication overuse headache: a systematic literature review. Paper presented at: American Headache Society Annual Scientific Meeting","author":"Deighton A","year":"2020","unstructured":"Deighton A, Johnston K, Dabirvaziri P, et\u00a0al. Acute migraine medication and medication overuse headache: a systematic literature review. Paper presented at: American Headache Society Annual Scientific Meeting 2020, Virtual."},{"key":"e_1_3_4_41_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40273-014-0153-y"},{"key":"e_1_3_4_42_1","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.71.2.193"},{"key":"e_1_3_4_43_1","doi-asserted-by":"publisher","DOI":"10.1615\/CritRevPhysRehabilMed.2013007945"},{"key":"e_1_3_4_44_1","unstructured":"CEA Registry. 2020. [cited 2020 Sep 8]. http:\/\/healtheconomicsdev.tuftsmedicalcenter.org\/cear2\/search\/search.aspx."},{"key":"e_1_3_4_45_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11136-019-02163-3"},{"key":"e_1_3_4_46_1","doi-asserted-by":"publisher","DOI":"10.1177\/0272989X11401031"},{"key":"e_1_3_4_47_1","doi-asserted-by":"publisher","DOI":"10.1080\/16501970510027312"},{"key":"e_1_3_4_48_1","volume-title":"Potential cost savings were identified across the Yale Health System when primarily using DysportVR vs. BotoxVR. 53rd Annual ASHP Midyear Clinical Meeting","author":"Al-Mazraawy B.","year":"2018","unstructured":"Al-Mazraawy B. Potential cost savings were identified across the Yale Health System when primarily using DysportVR vs. BotoxVR. 53rd Annual ASHP Midyear Clinical Meeting; 2018, Anaheim, CA."},{"key":"e_1_3_4_49_1","doi-asserted-by":"publisher","DOI":"10.2340\/16501977-2550"},{"key":"e_1_3_4_50_1","unstructured":"Eckwright D Burke J Gleason P. Real-world botulinum toxin (BT) utilization and treatment cost for cervical dystonia (CD) and limb spasticity (LS). AMCP Managed Care & Specialty Pharmacy Nexus Meeting; October 29\u2013November 1 2019 National Harbour MD."},{"issue":"5","key":"e_1_3_4_51_1","first-page":"412","article-title":"Cost-minimization analysis in the treatment of spasticity in children with cerebral palsy with botulinum toxin type A: an observational, longitudinal, retrospective study","volume":"40","author":"Tapias G","year":"2016","unstructured":"Tapias G, Garcia-Romero M, Crespo C, et\u00a0al. Cost-minimization analysis in the treatment of spasticity in children with cerebral palsy with botulinum toxin type A: an observational, longitudinal, retrospective study. Farm Hosp. 2016;40(5):412\u2013426.","journal-title":"Farm Hosp"},{"key":"e_1_3_4_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpn.2018.01.023"},{"key":"e_1_3_4_53_1","doi-asserted-by":"publisher","DOI":"10.30809\/phe.3.2015.5"},{"key":"e_1_3_4_54_1","doi-asserted-by":"publisher","DOI":"10.1186\/s40734-020-0083-0"},{"key":"e_1_3_4_55_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-017-8698-2"},{"issue":"4","key":"e_1_3_4_56_1","first-page":"459","article-title":"Respective potencies of Botox and Dysport: a double blind, randomised, crossover study in cervical dystonia","volume":"72","author":"Ranoux D","year":"2022","unstructured":"Ranoux D, Gury C, Fondarai J, et\u00a0al. Respective potencies of Botox and Dysport: a double blind, randomised, crossover study in cervical dystonia. J Neurol Neurosurg Psychiatry. 2022;72(4):459\u2013462.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"e_1_3_4_57_1","doi-asserted-by":"crossref","unstructured":"Han Y Stevens AL Dashtipour K et\u00a0al. A mixed treatment comparison to compare the efficacy and safety of botulinum toxin treatments for cervical dystonia. J Neurol. 2016;263(4):772\u2013780.","DOI":"10.1007\/s00415-016-8050-2"},{"key":"e_1_3_4_58_1","doi-asserted-by":"publisher","DOI":"10.3390\/toxins8030065"},{"key":"e_1_3_4_59_1","doi-asserted-by":"publisher","DOI":"10.5334\/tohm.185"},{"key":"e_1_3_4_60_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2021.11.264"}],"container-title":["Journal of Medical Economics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/13696998.2022.2092354","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,17]],"date-time":"2024-10-17T11:04:40Z","timestamp":1729163080000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/13696998.2022.2092354"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,15]]},"references-count":59,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12,31]]}},"alternative-id":["10.1080\/13696998.2022.2092354"],"URL":"https:\/\/doi.org\/10.1080\/13696998.2022.2092354","relation":{},"ISSN":["1369-6998","1941-837X"],"issn-type":[{"value":"1369-6998","type":"print"},{"value":"1941-837X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,15]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ijme20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ijme20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2022-03-11","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-06-16","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-06-17","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-07-15","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}